Targeted therapies: Expanding the role of FGFR3 inhibition in urothelial carcinoma
Author:
Publisher
Elsevier BV
Subject
Urology,Oncology
Reference73 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Bray;CA Cancer J Clin,2018
2. Program Populations (1969-2019)(Www.Seer.Cancer.Gov/Popdata),2021
3. Epidemiology of Bladder Cancer;Saginala;Med Sci,2020
4. Trends in the incidence and mortality of transitional cell carcinoma of the bladder for the last four decades in the USA: a SEER-based analysis;Al-Husseini;BMC Cancer,2019
5. European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2020 Update;Rouprêt;Eur Urol,2021
Cited by 19 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Discovery of TYRA-300: First Oral Selective FGFR3 Inhibitor for the Treatment of Urothelial Cancers and Achondroplasia;Journal of Medicinal Chemistry;2024-09-11
2. Human Biodistribution and Radiation Dosimetry of the Targeting Fibroblast Growth Factor Receptor 1-Positive Tumors Tracer [68Ga]Ga-DOTA-FGFR1-Peptide;Cancer Biotherapy and Radiopharmaceuticals;2024-07-18
3. Comprehensive molecular profiling identifies actionable biomarkers for patients from Thailand and the United Arab Emirates with advanced malignancies;Frontiers in Oncology;2024-05-10
4. A comprehensive overview of selective and novel fibroblast growth factor receptor inhibitors as a potential anticancer modality;Acta Pharmaceutica;2024-03-01
5. Current Landscape of Immune Checkpoint Inhibitors for Metastatic Urothelial Carcinoma: Is There a Role for Additional T-Cell Blockade?;Cancers;2023-12-27
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3